{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:51:43Z","timestamp":1791474703079,"version":"4.3.4"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"DOI":"10.1007\/s11418-026-02090-x","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:00:57Z","timestamp":1791471657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plant-derived phytochemicals for Alzheimer\u2019s disease: mechanisms of action, experimental evidence, and therapeutic perspectives"],"prefix":"10.1007","author":[{"given":"Janhavi","family":"Nimbalkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0304-3057","authenticated-orcid":false,"given":"Rushikesh","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2090_CR1","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.3390\/antiox13121440","volume":"13","author":"X Abadin","year":"2024","unstructured":"Abadin X, De Dios C, Zubillaga M et al (2024) Neuroinflammation in age-related neurodegenerative diseases: role of mitochondrial oxidative stress. Antioxidants 13:1440. https:\/\/doi.org\/10.3390\/antiox13121440","journal-title":"Antioxidants"},{"key":"2090_CR2","doi-asserted-by":"publisher","first-page":"947","DOI":"10.12991\/jrespharm.1693796","volume":"29","author":"A Tekade","year":"2025","unstructured":"Tekade A, Ratnaparkhi M, Shewale A et al (2025) Design and assessment of in-situ nasal gel incorporated with nanostructured cubosomes for the targeted therapy of schizophrenia. J Res Pharm 29:947\u2013958. https:\/\/doi.org\/10.12991\/jrespharm.1693796","journal-title":"J Res Pharm"},{"key":"2090_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s40001-025-02886-9","volume":"30","author":"J Zhang","year":"2025","unstructured":"Zhang J, Kong G, Yang J et al (2025) Pathological mechanisms and treatment progression of Alzheimer\u2019s disease. Eur J Med Res 30:625. https:\/\/doi.org\/10.1186\/s40001-025-02886-9","journal-title":"Eur J Med Res"},{"key":"2090_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","volume":"18","author":"E Nichols","year":"2019","unstructured":"Nichols E, Szoeke CEI, Vollset SE et al (2019) Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:88\u2013106. https:\/\/doi.org\/10.1016\/S1474-4422(18)30403-4","journal-title":"Lancet Neurol"},{"key":"2090_CR5","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.3390\/molecules25245789","volume":"25","author":"Z Breijyeh","year":"2020","unstructured":"Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer\u2019s disease: causes and treatment. Molecules 25:5789. https:\/\/doi.org\/10.3390\/molecules25245789","journal-title":"Molecules"},{"key":"2090_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jval.2024.10.3851","volume":"28","author":"J Fox","year":"2025","unstructured":"Fox J, Mearns ES, Li J et al (2025) Indirect costs of Alzheimer\u2019s disease: unpaid caregiver burden and patient productivity loss. Value Health 28:519\u2013526. https:\/\/doi.org\/10.1016\/j.jval.2024.10.3851","journal-title":"Value Health"},{"key":"2090_CR7","doi-asserted-by":"publisher","unstructured":"Tekade A, Shewale A, Shivakumar HN et al (2026) Cubosomes as versatile multifunctional lipid-based nanocarriers for drugdelivery: a comprehensive review. CPD 32. https:\/\/doi.org\/10.2174\/0113816128448670260318044416","DOI":"10.2174\/0113816128448670260318044416"},{"key":"2090_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2025.04.014","volume":"575","author":"KK Roy","year":"2025","unstructured":"Roy KK, Mehta DK, Das R (2025) Reevaluating Alzheimer\u2019s disease treatment: Can phytochemicals bridge the therapeutic Gap? Neuroscience 575:1\u201318. https:\/\/doi.org\/10.1016\/j.neuroscience.2025.04.014","journal-title":"Neuroscience"},{"key":"2090_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/nu17040653","volume":"17","author":"E Baranowska-W\u00f3jcik","year":"2025","unstructured":"Baranowska-W\u00f3jcik E, Gajowniczek-A\u0142asa D, Pawlikowska-Pawl\u0119ga B, Szwajgier D (2025) The potential role of phytochemicals in Alzheimer\u2019s disease. Nutrients 17:653. https:\/\/doi.org\/10.3390\/nu17040653","journal-title":"Nutrients"},{"key":"2090_CR10","doi-asserted-by":"publisher","first-page":"e140624231042","DOI":"10.2174\/0115734072309710240603065813","volume":"21","author":"VK Biswkarma","year":"2025","unstructured":"Biswkarma VK, Wadhawan S (2025) Phytoconstituents ameliorates Alzheimer\u2019s disease and cognitive impairments: a review of preclinical studies. CBC 21:e140624231042. https:\/\/doi.org\/10.2174\/0115734072309710240603065813","journal-title":"CBC"},{"key":"2090_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1871527322666230228102223","volume":"23","author":"H Varshney","year":"2024","unstructured":"Varshney H, Siddique YH (2024) Effect of natural plant products on Alzheimer\u2019s Disease. CNSNDDT 23:246\u2013261. https:\/\/doi.org\/10.2174\/1871527322666230228102223","journal-title":"CNSNDDT"},{"key":"2090_CR12","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2174\/1568026622666220815104305","volume":"22","author":"M Ayaz","year":"2022","unstructured":"Ayaz M, Nawaz A, Naz F et al (2022) Phytochemicals-based therapeutics against Alzheimer\u2019s Disease: An Update. CTMC 22:1811\u20131820. https:\/\/doi.org\/10.2174\/1568026622666220815104305","journal-title":"CTMC"},{"key":"2090_CR13","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/1871527320666210920120612","volume":"21","author":"S Gayathri","year":"2022","unstructured":"Gayathri S, Raghu CH, Fayaz SM (2022) Phytotherapeutics against Alzheimer\u2019s disease: mechanism, molecular targets and challenges for drug development. CNSNDDT 21:409\u2013426. https:\/\/doi.org\/10.2174\/1871527320666210920120612","journal-title":"CNSNDDT"},{"key":"2090_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.2174\/0115672050290462240222092303","volume":"21","author":"A Tekade","year":"2025","unstructured":"Tekade A, Kadam P, Jagdale S et al (2025) Exploring potential of nano-formulations in the treatment of Alzheimer\u2019s disease through nasal route. CAR 21:693\u2013709. https:\/\/doi.org\/10.2174\/0115672050290462240222092303","journal-title":"CAR"},{"key":"2090_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41419-025-08186-8","volume":"17","author":"AA Abdulkhaliq","year":"2026","unstructured":"Abdulkhaliq AA, Kim B, Almoghrabi YM et al (2026) Amyloid-\u03b2 and Tau in Alzheimer\u2019s disease: pathogenesis, mechanisms, and interplay. Cell Death Dis 17:21. https:\/\/doi.org\/10.1038\/s41419-025-08186-8","journal-title":"Cell Death Dis"},{"key":"2090_CR16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3390\/biom15060824","volume":"15","author":"X Hong","year":"2025","unstructured":"Hong X, Huang L, Lei F et al (2025) The role and pathogenesis of tau protein in Alzheimer\u2019s disease. Biomolecules 15:824. https:\/\/doi.org\/10.3390\/biom15060824","journal-title":"Biomolecules"},{"key":"2090_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jdad2020017","volume":"2","author":"AE Alkhalifa","year":"2025","unstructured":"Alkhalifa AE, Alkhalifa O, Durdanovic I et al (2025) Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s Disease: insights into pathophysiology and treatment. JDAD 2:17. https:\/\/doi.org\/10.3390\/jdad2020017","journal-title":"JDAD"},{"key":"2090_CR18","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/biom15050676","volume":"15","author":"J McGroarty","year":"2025","unstructured":"McGroarty J, Salinas S, Evans H et al (2025) Inflammasome-mediated neuroinflammation: a key driver in alzheimer\u2019s disease pathogenesis. Biomolecules 15:676. https:\/\/doi.org\/10.3390\/biom15050676","journal-title":"Biomolecules"},{"key":"2090_CR19","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J et al (2024) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Sig Transduct Target Ther 9:211. https:\/\/doi.org\/10.1038\/s41392-024-01911-3","journal-title":"Sig Transduct Target Ther"},{"key":"2090_CR20","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41593-022-01084-8","volume":"25","author":"J-H Lee","year":"2022","unstructured":"Lee J-H, Yang D-S, Goulbourne CN et al (2022) Faulty autolysosome acidification in Alzheimer\u2019s disease mouse models induces autophagic build-up of A\u03b2 in neurons, yielding senile plaques. Nat Neurosci 25:688\u2013701. https:\/\/doi.org\/10.1038\/s41593-022-01084-8","journal-title":"Nat Neurosci"},{"key":"2090_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12035-025-05417-z","volume":"63","author":"U Kochman","year":"2026","unstructured":"Kochman U, Sitka H, Ku\u017aniar J et al (2026) Targeted nanoparticles for drug delivery across the blood\u2013brain barrier in early and late stages of Alzheimer\u2019s Disease: a review. Mol Neurobiol 63:75. https:\/\/doi.org\/10.1007\/s12035-025-05417-z","journal-title":"Mol Neurobiol"},{"key":"2090_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","volume":"19","author":"EE Congdon","year":"2023","unstructured":"Congdon EE, Ji C, Tetlow AM et al (2023) Tau-targeting therapies for Alzheimer disease: current status and future directions. Nat Rev Neurol 19:715\u2013736. https:\/\/doi.org\/10.1038\/s41582-023-00883-2","journal-title":"Nat Rev Neurol"},{"key":"2090_CR23","doi-asserted-by":"publisher","first-page":"1217730","DOI":"10.3389\/fendo.2023.1217730","volume":"14","author":"GA Sidiropoulou","year":"2023","unstructured":"Sidiropoulou GA, Metaxas A, Kourti M (2023) Natural antioxidants that act against Alzheimer\u2019s disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action. Front Endocrinol 14:1217730. https:\/\/doi.org\/10.3389\/fendo.2023.1217730","journal-title":"Front Endocrinol"},{"key":"2090_CR24","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s10787-020-00751-1","volume":"28","author":"OA Olajide","year":"2020","unstructured":"Olajide OA, Sarker SD (2020) Alzheimer\u2019s disease: natural products as inhibitors of neuroinflammation. Inflammopharmacol 28:1439\u20131455. https:\/\/doi.org\/10.1007\/s10787-020-00751-1","journal-title":"Inflammopharmacol"},{"key":"2090_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/0115672050306008240321034006","volume":"21","author":"K Nagori","year":"2024","unstructured":"Nagori K, Pradhan M, Sharma M et al (2024) Current progress on central cholinergic receptors as therapeutic targets for Alzheimer\u2019s Disease. CAR 21:50\u201368. https:\/\/doi.org\/10.2174\/0115672050306008240321034006","journal-title":"CAR"},{"key":"2090_CR26","doi-asserted-by":"publisher","first-page":"105855","DOI":"10.1016\/j.nbd.2022.105855","volume":"173","author":"Z Gu","year":"2022","unstructured":"Gu Z, Cao H, Zuo C et al (2022) TFEB in Alzheimer\u2019s disease: from molecular mechanisms to therapeutic implications. Neurobiol Dis 173:105855. https:\/\/doi.org\/10.1016\/j.nbd.2022.105855","journal-title":"Neurobiol Dis"},{"key":"2090_CR27","doi-asserted-by":"publisher","first-page":"5538","DOI":"10.1039\/D0BM00756K","volume":"8","author":"C Qian","year":"2020","unstructured":"Qian C, Yuan C, Li C et al (2020) Multifunctional nano-enabled delivery systems in Alzheimer\u2019s disease management. Biomater Sci 8:5538\u20135554. https:\/\/doi.org\/10.1039\/D0BM00756K","journal-title":"Biomater Sci"},{"key":"2090_CR28","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.17219\/acem\/176051","volume":"33","author":"Y Gao","year":"2024","unstructured":"Gao Y, Liu Y, Li Y (2024) Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer\u2019s disease: A systematic review and meta-analysis. Adv Clin Exp Med 33:1179\u20131187. https:\/\/doi.org\/10.17219\/acem\/176051","journal-title":"Adv Clin Exp Med"},{"key":"2090_CR29","doi-asserted-by":"publisher","first-page":"e37799","DOI":"10.1097\/MD.0000000000037799","volume":"103","author":"Y Chen","year":"2024","unstructured":"Chen Y, Lai M, Tao M (2024) Evaluating the efficacy and safety of Alzheimer\u2019s disease drugs: A meta-analysis and systematic review. Medicine 103:e37799. https:\/\/doi.org\/10.1097\/MD.0000000000037799","journal-title":"Medicine"},{"key":"2090_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12883-024-03933-4","volume":"25","author":"YA Ismail","year":"2025","unstructured":"Ismail YA, Haitham Y, Walid M et al (2025) Efficacy of acetylcholinesterase inhibitors on reducing hippocampal atrophy rate: a systematic review and meta-analysis. BMC Neurol 25:60. https:\/\/doi.org\/10.1186\/s12883-024-03933-4","journal-title":"BMC Neurol"},{"key":"2090_CR31","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/ibra.12098","volume":"9","author":"B Tang","year":"2023","unstructured":"Tang B, Wang Y, Ren J (2023) Basic information about memantine and its treatment of Alzheimer\u2019s disease and other clinical applications. Ibrain 9:340\u2013348. https:\/\/doi.org\/10.1002\/ibra.12098","journal-title":"Ibrain"},{"key":"2090_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12779\/dnd.2025.24.1.1","volume":"24","author":"Y Kim","year":"2025","unstructured":"Kim Y, Kang DW, Kim GH et al (2025) Clinical practice guidelines for dementia: recommendations for cholinesterase inhibitors and memantine. Dement Neurocogn Disord 24:1. https:\/\/doi.org\/10.12779\/dnd.2025.24.1.1","journal-title":"Dement Neurocogn Disord"},{"key":"2090_CR33","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1093\/brain\/awad005","volume":"146","author":"R Perneczky","year":"2023","unstructured":"Perneczky R, Jessen F, Grimmer T et al (2023) Anti-amyloid antibody therapies in Alzheimer\u2019s disease. Brain 146:842\u2013849. https:\/\/doi.org\/10.1093\/brain\/awad005","journal-title":"Brain"},{"key":"2090_CR34","doi-asserted-by":"publisher","first-page":"e00570","DOI":"10.1016\/j.neurot.2025.e00570","volume":"22","author":"JL Cummings","year":"2025","unstructured":"Cummings JL (2025) Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer\u2019s disease: Strategies and research directions. Neurotherapeutics 22:e00570. https:\/\/doi.org\/10.1016\/j.neurot.2025.e00570","journal-title":"Neurotherapeutics"},{"key":"2090_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","volume":"14","author":"B-H Kim","year":"2025","unstructured":"Kim B-H, Kim S, Nam Y et al (2025) Second-generation anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: current landscape and future perspectives. Transl Neurodegener 14:6. https:\/\/doi.org\/10.1186\/s40035-025-00465-w","journal-title":"Transl Neurodegener"},{"key":"2090_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/153331750502000206","volume":"20","author":"JL Molinuevo","year":"2005","unstructured":"Molinuevo JL, Llad\u00f3 A, Rami L (2005) Memantine: targeting glutamate excitotoxicity in alzheimer\u2019s disease and other dementias. Am J Alzheimers Dis Other Demen 20:77\u201385. https:\/\/doi.org\/10.1177\/153331750502000206","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"2090_CR37","doi-asserted-by":"publisher","unstructured":"Chundu UC, Thiriveedhi SR, Bhatti C et al (2025) A systematic review of the efficacy and safety of anti-amyloid monoclonal antibodies in Alzheimer\u2019s disease. https:\/\/doi.org\/10.7759\/cureus.85377. Cureus","DOI":"10.7759\/cureus.85377"},{"key":"2090_CR38","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1002\/ptr.8435","volume":"39","author":"RS Bhattacharya","year":"2025","unstructured":"Bhattacharya RS, Singh R, Panghal A et al (2025) Multi-targeting phytochemicals for Alzheimer\u2019s disease. Phytother Res 39:1453\u20131483. https:\/\/doi.org\/10.1002\/ptr.8435","journal-title":"Phytother Res"},{"key":"2090_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10048-025-00821-y","volume":"26","author":"K Abbas","year":"2025","unstructured":"Abbas K, Mustafa M, Alam M et al (2025) Multi-target approach to Alzheimer\u2019s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms. Neurogenetics 26:39. https:\/\/doi.org\/10.1007\/s10048-025-00821-y","journal-title":"Neurogenetics"},{"key":"2090_CR40","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jep.2016.06.052","volume":"194","author":"Y Jaiswal","year":"2016","unstructured":"Jaiswal Y, Liang Z, Zhao Z (2016) Botanical drugs in ayurveda and traditional chinese medicine. J Ethnopharmacol 194:245\u2013259. https:\/\/doi.org\/10.1016\/j.jep.2016.06.052","journal-title":"J Ethnopharmacol"},{"key":"2090_CR41","doi-asserted-by":"publisher","first-page":"100223","DOI":"10.1016\/j.hsr.2025.100223","volume":"15","author":"SK Kadiri","year":"2025","unstructured":"Kadiri SK, Tiwari P (2025) Integrating traditional medicine with network pharmacology for Alzheimer\u2019s treatment. Health Sci Rev 15:100223. https:\/\/doi.org\/10.1016\/j.hsr.2025.100223","journal-title":"Health Sci Rev"},{"key":"2090_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/antiox10010023","volume":"10","author":"MA Rahman","year":"2020","unstructured":"Rahman MA, Rahman MH, Biswas P et al (2020) Potential therapeutic role of phytochemicals to mitigate mitochondrial dysfunctions in Alzheimer\u2019s disease. Antioxidants 10:23. https:\/\/doi.org\/10.3390\/antiox10010023","journal-title":"Antioxidants"},{"key":"2090_CR43","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/pharmaceutics15030749","volume":"15","author":"S Shoaib","year":"2023","unstructured":"Shoaib S, Ansari MA, Fatease AA et al (2023) Plant-Derived Bioactive Compounds in the Management of Neurodegenerative Disorders: Challenges, Future Directions and Molecular Mechanisms Involved in Neuroprotection. Pharmaceutics 15:749. https:\/\/doi.org\/10.3390\/pharmaceutics15030749","journal-title":"Pharmaceutics"},{"key":"2090_CR44","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3390\/jpm12091515","volume":"12","author":"J Sharifi-Rad","year":"2022","unstructured":"Sharifi-Rad J, Rapposelli S, Sestito S et al (2022) Multi-target mechanisms of phytochemicals in Alzheimer\u2019s disease: effects on oxidative stress, neuroinflammation and protein aggregation. JPM 12:1515. https:\/\/doi.org\/10.3390\/jpm12091515","journal-title":"JPM"},{"key":"2090_CR45","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.3390\/antiox11122345","volume":"11","author":"V Ngo","year":"2022","unstructured":"Ngo V, Duennwald ML (2022) Nrf2 and oxidative stress: a general overview of mechanisms and implications in human disease. Antioxidants 11:2345. https:\/\/doi.org\/10.3390\/antiox11122345","journal-title":"Antioxidants"},{"key":"2090_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.31254\/phyto.2023.12307","volume":"12","author":"RA Dar","year":"2023","unstructured":"Dar RA, Shahnawaz M, Ahanger MA, Majid IU (2023) Exploring the diverse bioactive compounds from medicinal plants: a review. J Phytopharmacol 12:189\u2013195. https:\/\/doi.org\/10.31254\/phyto.2023.12307","journal-title":"J Phytopharmacol"},{"key":"2090_CR47","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.32604\/phyton.2025.065750","volume":"94","author":"A Assouguem","year":"2025","unstructured":"Assouguem A, Annemer S, Kara M, Lazraq A (2025) Innovative approaches in the extraction, identification, and application of secondary metabolites from plants. Phyton 94:1631\u20131668. https:\/\/doi.org\/10.32604\/phyton.2025.065750","journal-title":"Phyton"},{"key":"2090_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/antiox13060651","volume":"13","author":"GLDO Pagotto","year":"2024","unstructured":"Pagotto GLDO, Santos LMOD, Osman N et al (2024) Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer\u2019s Dementia: Clinical trial systematic review. Antioxidants 13:651. https:\/\/doi.org\/10.3390\/antiox13060651","journal-title":"Antioxidants"},{"key":"2090_CR49","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/medicina58081025","volume":"58","author":"H Ding","year":"2022","unstructured":"Ding H, Reiss AB, Pinkhasov A, Kasselman LJ (2022) Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer\u2019s Disease, and Other Dementias. Medicina 58:1025. https:\/\/doi.org\/10.3390\/medicina58081025","journal-title":"Medicina"},{"key":"2090_CR50","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13195-018-0457-9","volume":"10","author":"K-X Dou","year":"2018","unstructured":"Dou K-X, Tan M-S, Tan C-C et al (2018) Comparative safety and effectiveness of cholinesterase inhibitors and memantine for Alzheimer\u2019s disease: a network meta-analysis of 41 randomized controlled trials. Alz Res Therapy 10:126. https:\/\/doi.org\/10.1186\/s13195-018-0457-9","journal-title":"Alz Res Therapy"},{"key":"2090_CR51","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1089\/acm.2008.0018","volume":"14","author":"C Calabrese","year":"2008","unstructured":"Calabrese C, Gregory WL, Leo M et al (2008) Effects of a Standardized Bacopa monnieri Extract on Cognitive Performance, Anxiety, and Depression in the Elderly: A Randomized, Double-Blind, Placebo-Controlled Trial. J Altern Complement Med 14:707\u2013713. https:\/\/doi.org\/10.1089\/acm.2008.0018","journal-title":"J Altern Complement Med"},{"key":"2090_CR52","doi-asserted-by":"publisher","first-page":"102990","DOI":"10.1016\/j.explore.2024.02.008","volume":"20","author":"M Delfan","year":"2024","unstructured":"Delfan M, Kordestani-Moghaddam P, Gholami M et al (2024) Evaluating the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: A triple-blinded, randomized, placebo-controlled trial. EXPLORE 20:102990. https:\/\/doi.org\/10.1016\/j.explore.2024.02.008","journal-title":"EXPLORE"},{"key":"2090_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1745-7254.2006.00255.x","volume":"27","author":"R Wang","year":"2006","unstructured":"Wang R, Yan H, Tang X (2006) Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine1. Acta Pharmacol Sin 27:1\u201326. https:\/\/doi.org\/10.1111\/j.1745-7254.2006.00255.x","journal-title":"Acta Pharmacol Sin"},{"key":"2090_CR54","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3233\/JAD-2007-11411","volume":"11","author":"JT Coyle","year":"2007","unstructured":"Coyle JT, Geerts H, Sorra K, Amatniek J (2007) Beyond In Vitro Data: A Review of In Vivo Evidence Regarding the Allosteric Potentiating Effect of Galantamine on Nicotinic Acetylcholine Receptors in Alzheimer\u2019s Neuropathology. JAD 11:491\u2013507. https:\/\/doi.org\/10.3233\/JAD-2007-11411","journal-title":"JAD"},{"key":"2090_CR55","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11011-025-01740-5","volume":"40","author":"P Yadav","year":"2025","unstructured":"Yadav P, Dabas A, Singh R (2025) Six-membered N-heterocyclic alkaloids as ChE inhibitors in alzheimer\u2019s disease treatment. Metab Brain Dis 40:309. https:\/\/doi.org\/10.1007\/s11011-025-01740-5","journal-title":"Metab Brain Dis"},{"key":"2090_CR56","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11010-023-04922-w","volume":"480","author":"AA Md","year":"2025","unstructured":"Md AA, Dehbia Z, Nafady MH et al (2025) Flavonoids and Alzheimer\u2019s disease: reviewing the evidence for neuroprotective potential. Mol Cell Biochem 480:43\u201373. https:\/\/doi.org\/10.1007\/s11010-023-04922-w","journal-title":"Mol Cell Biochem"},{"key":"2090_CR57","doi-asserted-by":"publisher","first-page":"e3964","DOI":"10.1002\/cbf.3964","volume":"42","author":"AM Nezhad Salari","year":"2024","unstructured":"Nezhad Salari AM, Rasoulizadeh Z, Shabgah AG et al (2024) Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders. Cell Biochem Function 42:e3964. https:\/\/doi.org\/10.1002\/cbf.3964","journal-title":"Cell Biochem Function"},{"key":"2090_CR58","doi-asserted-by":"publisher","first-page":"14835","DOI":"10.3390\/ijms232314835","volume":"23","author":"A Calderaro","year":"2022","unstructured":"Calderaro A, Patan\u00e8 GT, Tellone E et al (2022) The Neuroprotective Potentiality of Flavonoids on Alzheimer\u2019s Disease. IJMS 23:14835. https:\/\/doi.org\/10.3390\/ijms232314835","journal-title":"IJMS"},{"key":"2090_CR59","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1007\/s10068-024-01656-3","volume":"33","author":"H Kim","year":"2024","unstructured":"Kim H, Kang S, Go G (2024) Exploring the multifaceted role of ginkgolides and bilobalide from Ginkgo biloba in mitigating metabolic disorders. Food Sci Biotechnol 33:2903\u20132917. https:\/\/doi.org\/10.1007\/s10068-024-01656-3","journal-title":"Food Sci Biotechnol"},{"key":"2090_CR60","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/1028415X.2023.2180865","volume":"27","author":"M Farzan","year":"2024","unstructured":"Farzan M, Farzan M, Shahrani M et al (2024) Neuroprotective properties of Betulin, Betulinic acid, and Ursolic acid as triterpenoids derivatives: a comprehensive review of mechanistic studies. Nutr Neurosci 27:223\u2013240. https:\/\/doi.org\/10.1080\/1028415X.2023.2180865","journal-title":"Nutr Neurosci"},{"key":"2090_CR61","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/app16010494","volume":"16","author":"JM Espinosa-Cabello","year":"2026","unstructured":"Espinosa-Cabello JM, Fern\u00e1ndez-Aparicio \u00c1, Gonz\u00e1lez-Jim\u00e9nez E et al (2026) Oleanolic Acid and Alzheimer\u2019s Disease: Mechanistic Hypothesis of Therapeutic Potential. Appl Sci 16:494. https:\/\/doi.org\/10.3390\/app16010494","journal-title":"Appl Sci"},{"key":"2090_CR62","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.3390\/app14093898","volume":"14","author":"E Lima","year":"2024","unstructured":"Lima E, Medeiros J (2024) Terpenes as Potential Anti-Alzheimer\u2019s Disease Agents. Appl Sci 14:3898. https:\/\/doi.org\/10.3390\/app14093898","journal-title":"Appl Sci"},{"key":"2090_CR63","doi-asserted-by":"publisher","first-page":"5754","DOI":"10.3390\/ijms27135754","volume":"27","author":"K St\u0119pnik","year":"2026","unstructured":"St\u0119pnik K (2026) Curcumin in Alzheimer\u2019s Disease: From Mechanistic Insights to Translational Challenges and Emerging Curcuminoid Strategies. IJMS 27:5754. https:\/\/doi.org\/10.3390\/ijms27135754","journal-title":"IJMS"},{"key":"2090_CR64","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12986-024-00792-1","volume":"21","author":"A Azargoonjahromi","year":"2024","unstructured":"Azargoonjahromi A, Abutalebian F (2024) Unraveling the therapeutic efficacy of resveratrol in Alzheimer\u2019s disease: an umbrella review of systematic evidence. Nutr Metab (Lond) 21:15. https:\/\/doi.org\/10.1186\/s12986-024-00792-1","journal-title":"Nutr Metab (Lond)"},{"key":"2090_CR65","doi-asserted-by":"publisher","first-page":"e70496","DOI":"10.1002\/fsn3.70496","volume":"13","author":"G Chen","year":"2025","unstructured":"Chen G, Su Y, Chen S et al (2025) Polyphenols and Alzheimer\u2019s Disease: A Review on Molecular and Therapeutic Insights With In Silico Support. Food Sci Nutr 13:e70496. https:\/\/doi.org\/10.1002\/fsn3.70496","journal-title":"Food Sci Nutr"},{"key":"2090_CR66","doi-asserted-by":"publisher","first-page":"972379","DOI":"10.3389\/fnut.2022.972379","volume":"9","author":"U Fatima","year":"2022","unstructured":"Fatima U, Roy S, Ahmad S et al (2022) Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation. Front Nutr 9:972379. https:\/\/doi.org\/10.3389\/fnut.2022.972379","journal-title":"Front Nutr"},{"key":"2090_CR67","doi-asserted-by":"publisher","unstructured":"Sharma S, Verma J, Lakhanpal A et al (2025) Exploring the Therapeutic Potential of Panax Ginseng: A Comprehensive Review of Its Pharmacological Applications. https:\/\/doi.org\/10.2174\/0127724344376497251007045815. RAAIDD 20:","DOI":"10.2174\/0127724344376497251007045815"},{"key":"2090_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/biom16010007","volume":"16","author":"S Pavlov","year":"2025","unstructured":"Pavlov S, Prajapati SK, Yadav D et al (2025) Advances in Bioactive Compounds from Plants and Their Applications in Alzheimer\u2019s Disease. Biomolecules 16:7. https:\/\/doi.org\/10.3390\/biom16010007","journal-title":"Biomolecules"},{"key":"2090_CR69","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1039\/D5FO04185F","volume":"17","author":"M Tao","year":"2026","unstructured":"Tao M, Mao J, Wang G et al (2026) Ellagitannins from red raspberry (Rubus idaeus L.): a comprehensive review on chemistry characteristics and beneficial effects. Food Funct 17:1127\u20131144. https:\/\/doi.org\/10.1039\/D5FO04185F","journal-title":"Food Funct"},{"key":"2090_CR70","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.1007\/s00210-024-03102-x","volume":"397","author":"EHM Hassanein","year":"2024","unstructured":"Hassanein EHM, Althagafy HS, Baraka MA et al (2024) The promising antioxidant effects of lignans: Nrf2 activation comes into view. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 397:6439\u20136458. https:\/\/doi.org\/10.1007\/s00210-024-03102-x","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"2090_CR71","doi-asserted-by":"publisher","first-page":"119065","DOI":"10.1016\/j.jep.2024.119065","volume":"338","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Wang Z, Wang W et al (2025) Ganoderma lucidum polysaccharide alleviates cognitive dysfunction by inhibiting neuroinflammation via NLRP3\/NF-\u03baB signaling pathway. J Ethnopharmacol 338:119065. https:\/\/doi.org\/10.1016\/j.jep.2024.119065","journal-title":"J Ethnopharmacol"},{"key":"2090_CR72","doi-asserted-by":"publisher","first-page":"1496661","DOI":"10.3389\/fphar.2024.1496661","volume":"15","author":"Y Wei","year":"2024","unstructured":"Wei Y, Li H, Li Y et al (2024) Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies. Front Pharmacol 15:1496661. https:\/\/doi.org\/10.3389\/fphar.2024.1496661","journal-title":"Front Pharmacol"},{"key":"2090_CR73","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12031-012-9737-1","volume":"47","author":"M Jazvin\u0161\u0107ak Jembrek","year":"2012","unstructured":"Jazvin\u0161\u0107ak Jembrek M, Vukovi\u0107 L, Puhovi\u0107 J et al (2012) Neuroprotective Effect of Quercetin Against Hydrogen Peroxide-induced Oxidative Injury in P19 Neurons. J Mol Neurosci 47:286\u2013299. https:\/\/doi.org\/10.1007\/s12031-012-9737-1","journal-title":"J Mol Neurosci"},{"key":"2090_CR74","doi-asserted-by":"publisher","first-page":"1593264","DOI":"10.3389\/fphar.2025.1593264","volume":"16","author":"M Adnan","year":"2025","unstructured":"Adnan M, Siddiqui AJ, Bardakci F et al (2025) Neuroprotective potential of quercetin in Alzheimer\u2019s disease: targeting oxidative stress, mitochondrial dysfunction, and amyloid-\u03b2 aggregation. Front Pharmacol 16:1593264. https:\/\/doi.org\/10.3389\/fphar.2025.1593264","journal-title":"Front Pharmacol"},{"key":"2090_CR75","doi-asserted-by":"publisher","first-page":"5698119","DOI":"10.1155\/2024\/5698119","volume":"2024","author":"M Cheng","year":"2024","unstructured":"Cheng M, Yuan C, Ju Y et al (2024) Quercetin Attenuates Oxidative Stress and Apoptosis in Brain Tissue of APP\/PS1 Double Transgenic AD Mice by Regulating Keap1\/Nrf2\/HO-1 Pathway to Improve Cognitive Impairment. Behav Neurol 2024:5698119. https:\/\/doi.org\/10.1155\/2024\/5698119","journal-title":"Behav Neurol"},{"key":"2090_CR76","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/agm2.12361","volume":"7","author":"Y Ruan","year":"2024","unstructured":"Ruan Y, Luo H, Tang J et al (2024) Curcumin inhibits oxidative stress and autophagy in C17.2 neural stem cell through ERK1 \/2 signaling pathways. Aging Med 7:559\u2013570. https:\/\/doi.org\/10.1002\/agm2.12361","journal-title":"Aging Med"},{"key":"2090_CR77","doi-asserted-by":"publisher","first-page":"111731","DOI":"10.1016\/j.exger.2022.111731","volume":"161","author":"B De Oliveira Zanuso","year":"2022","unstructured":"De Oliveira Zanuso B, De Oliveira Dos Santos AR, Miola VFB et al (2022) Panax ginseng and aging related disorders: A systematic review. Exp Gerontol 161:111731. https:\/\/doi.org\/10.1016\/j.exger.2022.111731","journal-title":"Exp Gerontol"},{"key":"2090_CR78","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jep.2016.07.073","volume":"197","author":"MD Nemetchek","year":"2017","unstructured":"Nemetchek MD, Stierle AA, Stierle DB, Lurie DI (2017) The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain. J Ethnopharmacol 197:92\u2013100. https:\/\/doi.org\/10.1016\/j.jep.2016.07.073","journal-title":"J Ethnopharmacol"},{"key":"2090_CR79","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.3390\/nu17223538","volume":"17","author":"M Wici\u0144ski","year":"2025","unstructured":"Wici\u0144ski M, Fajkiel-Madajczyk A, W\u00f3jcicki J et al (2025) The Role of Bacopa monnieri in Alzheimer\u2019s Disease: Mechanisms and Potential Clinical Use\u2014A. Rev Nutrients 17:3538. https:\/\/doi.org\/10.3390\/nu17223538","journal-title":"Rev Nutrients"},{"key":"2090_CR80","doi-asserted-by":"publisher","first-page":"786","DOI":"10.62641\/aep.v52i6.1713","volume":"52","author":"Y Feng","year":"2024","unstructured":"Feng Y, Yu X, Han J (2024) Quercetin Regulates the Polarization of Microglia through the NRF2\/HO1 Pathway and Mitigates Alzheimer\u2019s Disease. Actas Esp Psiquiatr 52:786\u2013799. https:\/\/doi.org\/10.62641\/aep.v52i6.1713","journal-title":"Actas Esp Psiquiatr"},{"key":"2090_CR81","doi-asserted-by":"publisher","first-page":"8947","DOI":"10.1111\/jcmm.16855","volume":"25","author":"Y Han","year":"2021","unstructured":"Han Y, Chen R, Lin Q et al (2021) Curcumin improves memory deficits by inhibiting HMGB1-RAGE\/TLR4\u2010NF\u2010\u03baB signalling pathway in APPswe\/PS1dE9 transgenic mice hippocampus. J Cell Mol Medi 25:8947\u20138956. https:\/\/doi.org\/10.1111\/jcmm.16855","journal-title":"J Cell Mol Medi"},{"key":"2090_CR82","doi-asserted-by":"publisher","first-page":"108012","DOI":"10.1016\/j.bioorg.2024.108012","volume":"154","author":"X Zhu","year":"2025","unstructured":"Zhu X, Xu J-B, Gao F, Wan L-X (2025) Advances in the structural modification of Alzheimer\u2019s disease drug \u2013 Huperzine A. Bioorg Chem 154:108012. https:\/\/doi.org\/10.1016\/j.bioorg.2024.108012","journal-title":"Bioorg Chem"},{"key":"2090_CR83","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jphs.2024.07.008","volume":"156","author":"S Nozaki","year":"2024","unstructured":"Nozaki S, Hijioka M, Wen X et al (2024) Galantamine suppresses \u03b1-synuclein aggregation by inducing autophagy via the activation of \u03b17 nicotinic acetylcholine receptors. J Pharmacol Sci 156:102\u2013114. https:\/\/doi.org\/10.1016\/j.jphs.2024.07.008","journal-title":"J Pharmacol Sci"},{"key":"2090_CR84","doi-asserted-by":"publisher","first-page":"118371","DOI":"10.1016\/j.ejmech.2025.118371","volume":"302","author":"U Khan","year":"2026","unstructured":"Khan U, Ahmad M, Tuba M et al (2026) Natural alkaloids with therapeutic potential against Alzheimer\u2019s disease through cholinesterase inhibition. Eur J Med Chem 302:118371. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118371","journal-title":"Eur J Med Chem"},{"key":"2090_CR85","doi-asserted-by":"publisher","first-page":"7971","DOI":"10.3390\/molecules27227971","volume":"27","author":"Y Liao","year":"2022","unstructured":"Liao Y, Mai X, Wu X et al (2022) Exploring the Inhibition of Quercetin on Acetylcholinesterase by Multispectroscopic and In Silico Approaches and Evaluation of Its Neuroprotective Effects on PC12 Cells. Molecules 27:7971. https:\/\/doi.org\/10.3390\/molecules27227971","journal-title":"Molecules"},{"key":"2090_CR86","doi-asserted-by":"publisher","unstructured":"Tekade A, Shinde R, Nimbalkar J et al (2026) Development and evaluation of intranasal nanostructured lipid carriers encapsulating donepezil HCl and Caesalpinia bonduc seed extract for targeting Alzheimer\u2019s disease: in vitro and in vivo evaluation. J Drug Target 1\u201318. https:\/\/doi.org\/10.1080\/1061186X.2026.2671309","DOI":"10.1080\/1061186X.2026.2671309"},{"key":"2090_CR87","doi-asserted-by":"publisher","first-page":"103091","DOI":"10.1016\/j.nxmate.2026.103091","volume":"13","author":"R Shinde","year":"2026","unstructured":"Shinde R, Nimbalkar J, Shivakumar HN (2026) Chitosan-based nanoplatforms for drug delivery and biomedical applications: Recent advances and therapeutic perspectives. Next Mater 13:103091. https:\/\/doi.org\/10.1016\/j.nxmate.2026.103091","journal-title":"Next Mater"},{"key":"2090_CR88","doi-asserted-by":"publisher","first-page":"117401","DOI":"10.1016\/j.ejmech.2025.117401","volume":"288","author":"MK Hussain","year":"2025","unstructured":"Hussain MK, Ahmad M, Khatoon S et al (2025) Phytomolecules as Alzheimer\u2019s therapeutics: A comprehensive review. Eur J Med Chem 288:117401. https:\/\/doi.org\/10.1016\/j.ejmech.2025.117401","journal-title":"Eur J Med Chem"},{"key":"2090_CR89","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","volume":"102","author":"M Garcia-Alloza","year":"2007","unstructured":"Garcia-Alloza M, Borrelli LA, Rozkalne A et al (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 102:1095\u20131104. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04613.x","journal-title":"J Neurochem"},{"key":"2090_CR90","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s44345-025-00038-4","volume":"2","author":"KG Reddy","year":"2025","unstructured":"Reddy KG, Swain S, Aryan A, Metya AK (2025) Molecular insights into curcumin\u2019s Anti-Alzheimer\u2019s potential through Amyloid-\u03b2 and Tau interactions. Discov Mol 2:30. https:\/\/doi.org\/10.1007\/s44345-025-00038-4","journal-title":"Discov Mol"},{"key":"2090_CR91","doi-asserted-by":"publisher","first-page":"640758","DOI":"10.3389\/fphar.2021.640758","volume":"12","author":"Y Wu","year":"2021","unstructured":"Wu Y, Chen Q, Wen B et al (2021) Berberine Reduces A\u03b242 Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress. Front Pharmacol 12:640758. https:\/\/doi.org\/10.3389\/fphar.2021.640758","journal-title":"Front Pharmacol"},{"key":"2090_CR92","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/antiox13040393","volume":"13","author":"LJ Valotto Neto","year":"2024","unstructured":"Valotto Neto LJ, Reverete De Araujo M, Moretti Junior RC et al (2024) Investigating the Neuroprotective and Cognitive-Enhancing Effects of Bacopa monnieri: A Systematic Review Focused on Inflammation, Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis. Antioxidants 13:393. https:\/\/doi.org\/10.3390\/antiox13040393","journal-title":"Antioxidants"},{"key":"2090_CR93","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00018-003-3080-1","volume":"60","author":"B Ahlemeyer","year":"2003","unstructured":"Ahlemeyer B, Krieglstein J (2003) Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci (CMLS) 60:1779\u20131792. https:\/\/doi.org\/10.1007\/s00018-003-3080-1","journal-title":"Cell Mol Life Sci (CMLS)"},{"key":"2090_CR94","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11011-025-01610-0","volume":"40","author":"F Mehrnoosh","year":"2025","unstructured":"Mehrnoosh F, Rezaei D, Pakmehr SA et al (2025) The role of Panax ginseng in neurodegenerative disorders: mechanisms, benefits, and future directions. Metab Brain Dis 40:183. https:\/\/doi.org\/10.1007\/s11011-025-01610-0","journal-title":"Metab Brain Dis"},{"key":"2090_CR95","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s43088-025-00675-1","volume":"14","author":"K Suvaiv, Singh","year":"2025","unstructured":"Suvaiv, Singh K, Hasan SM et al (2025) Huperzine A: a natural acetylcholinesterase inhibitor with multifunctional neuroprotective effects. Beni-Suef Univ J Basic Appl Sci 14:82. https:\/\/doi.org\/10.1186\/s43088-025-00675-1","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"2090_CR96","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.3390\/foods13111774","volume":"13","author":"G Genchi","year":"2024","unstructured":"Genchi G, Lauria G, Catalano A et al (2024) Neuroprotective Effects of Curcumin in Neurodegenerative Diseases. Foods 13:1774. https:\/\/doi.org\/10.3390\/foods13111774","journal-title":"Foods"},{"key":"2090_CR97","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jconrel.2024.01.047","volume":"367","author":"B Singh","year":"2024","unstructured":"Singh B, Day CM, Abdella S, Garg S (2024) Alzheimer\u2019s disease current therapies, novel drug delivery systems and future directions for better disease management. J Controlled Release 367:402\u2013424. https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.047","journal-title":"J Controlled Release"},{"key":"2090_CR98","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s43088-024-00498-6","volume":"13","author":"AA Amer","year":"2024","unstructured":"Amer AA, Kassem SH, Hussein MA (2024) Chemical composition, antioxidant, cytotoxic, antiviral, and lung-protective activities of Salvia officinalis L. ethanol extract herb growing in Sinai, Egypt. Beni-Suef Univ J Basic Appl Sci 13:39. https:\/\/doi.org\/10.1186\/s43088-024-00498-6","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"2090_CR99","doi-asserted-by":"publisher","first-page":"2559122","DOI":"10.1080\/07853890.2025.2559122","volume":"57","author":"J Jiang","year":"2025","unstructured":"Jiang J, Han R, Ren H et al (2025) A review of neuroprotective properties of Centella asiatica (L.) Urb. and its therapeutic effects. Ann Med 57:2559122. https:\/\/doi.org\/10.1080\/07853890.2025.2559122","journal-title":"Ann Med"},{"key":"2090_CR100","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/plants13060771","volume":"13","author":"V Lerose","year":"2024","unstructured":"Lerose V, Ponticelli M, Benedetto N et al (2024) Withania somnifera (L.) Dunal, a Potential Source of Phytochemicals for Treating Neurodegenerative Diseases: A Systematic Review. Plants 13:771. https:\/\/doi.org\/10.3390\/plants13060771","journal-title":"Plants"},{"key":"2090_CR101","doi-asserted-by":"publisher","first-page":"1431894","DOI":"10.3389\/fphar.2024.1431894","volume":"15","author":"S Li","year":"2024","unstructured":"Li S, Hou Z, Ye T et al (2024) Saponin components in Polygala tenuifolia as potential candidate drugs for treating dementia. Front Pharmacol 15:1431894. https:\/\/doi.org\/10.3389\/fphar.2024.1431894","journal-title":"Front Pharmacol"},{"key":"2090_CR102","doi-asserted-by":"publisher","first-page":"16229","DOI":"10.1007\/s12035-025-05234-4","volume":"62","author":"S Patel","year":"2025","unstructured":"Patel S, Thornton A, Parmar MS (2025) Resveratrol\u2019s Multifaceted Potential in Alzheimer\u2019s Disease: Insights from Preclinical and Clinical Evidence. Mol Neurobiol 62:16229\u201316260. https:\/\/doi.org\/10.1007\/s12035-025-05234-4","journal-title":"Mol Neurobiol"},{"key":"2090_CR103","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s42452-025-06876-8","volume":"7","author":"AM El-Feky","year":"2025","unstructured":"El-Feky AM, El-Abd EAW, Deabes DAH, El-Rashedy AA (2025) Phytochemical investigation and in vitro biological evaluation of Beta vulgaris leaves as anti-diabetic, anti-Alzheimer\u2019s and anti-inflammatory agents with computer-guided docking study. Discov Appl Sci 7:1040. https:\/\/doi.org\/10.1007\/s42452-025-06876-8","journal-title":"Discov Appl Sci"},{"key":"2090_CR104","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3390\/biom15030452","volume":"15","author":"T Sargsyan","year":"2025","unstructured":"Sargsyan T, Simonyan HM, Stepanyan L et al (2025) Neuroprotective Properties of Clove (Syzygium aromaticum): State of the Art and Future Pharmaceutical Applications for Alzheimer\u2019s Disease. Biomolecules 15:452. https:\/\/doi.org\/10.3390\/biom15030452","journal-title":"Biomolecules"},{"key":"2090_CR105","doi-asserted-by":"publisher","first-page":"1511011","DOI":"10.3389\/fphar.2025.1511011","volume":"16","author":"H Luo","year":"2025","unstructured":"Luo H, Wei S, Fu S, Han L (2025) Role of Achyranthes aspera in neurodegenerative diseases: current evidence and future directions. Front Pharmacol 16:1511011. https:\/\/doi.org\/10.3389\/fphar.2025.1511011","journal-title":"Front Pharmacol"},{"key":"2090_CR106","doi-asserted-by":"publisher","first-page":"15238","DOI":"10.3390\/ijms232315238","volume":"23","author":"Y-P Yan","year":"2022","unstructured":"Yan Y-P, Chen J-Y, Lu J-H (2022) Disease-Modifying Activity of Huperzine A on Alzheimer\u2019s Disease: Evidence from Preclinical Studies on Rodent Models. IJMS 23:15238. https:\/\/doi.org\/10.3390\/ijms232315238","journal-title":"IJMS"},{"key":"2090_CR107","doi-asserted-by":"publisher","first-page":"876614","DOI":"10.3389\/fphar.2022.876614","volume":"13","author":"I Piccialli","year":"2022","unstructured":"Piccialli I, Tedeschi V, Caputo L et al (2022) Exploring the Therapeutic Potential of Phytochemicals in Alzheimer\u2019s Disease: Focus on Polyphenols and Monoterpenes. Front Pharmacol 13:876614. https:\/\/doi.org\/10.3389\/fphar.2022.876614","journal-title":"Front Pharmacol"},{"key":"2090_CR108","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1002\/iub.2862","volume":"76","author":"L Zhou","year":"2024","unstructured":"Zhou L, Tan F, Zhang X et al (2024) Neuroprotection and mechanisms of ginsenosides in nervous system diseases: Progress and perspectives. IUBMB Life 76:862\u2013882. https:\/\/doi.org\/10.1002\/iub.2862","journal-title":"IUBMB Life"},{"key":"2090_CR109","doi-asserted-by":"publisher","first-page":"100697","DOI":"10.37349\/en.2025.100697","volume":"4","author":"AVD Thomas","year":"2025","unstructured":"Thomas AVD T D (2025) Plant extracts and phytochemicals targeting Alzheimer\u2019s through acetylcholinesterase inhibition. Explor Neurosci 4:100697. https:\/\/doi.org\/10.37349\/en.2025.100697","journal-title":"Explor Neurosci"},{"key":"2090_CR110","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/ph16070941","volume":"16","author":"J Park","year":"2023","unstructured":"Park J, Lee C, Kim YT (2023) Effects of Natural Product-Derived Compounds on Inflammatory Pain via Regulation of Microglial Activation. Pharmaceuticals 16:941. https:\/\/doi.org\/10.3390\/ph16070941","journal-title":"Pharmaceuticals"},{"key":"2090_CR111","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.dcmed.2025.05.002","volume":"8","author":"D Kirubakaran","year":"2025","unstructured":"Kirubakaran D (2025) Herbal remedies for Alzheimer\u2019s disease: neuroprotective mechanisms and cognitive enhancement potential. Digit Chin Med 8:183\u2013195. https:\/\/doi.org\/10.1016\/j.dcmed.2025.05.002","journal-title":"Digit Chin Med"},{"key":"2090_CR112","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s11033-021-06236-w","volume":"48","author":"VT Shalini","year":"2021","unstructured":"Shalini VT, Neelakanta SJ, Sriranjini JS (2021) Neuroprotection with Bacopa monnieri\u2013A review of experimental evidence. Mol Biol Rep 48:2653\u20132668. https:\/\/doi.org\/10.1007\/s11033-021-06236-w","journal-title":"Mol Biol Rep"},{"key":"2090_CR113","doi-asserted-by":"publisher","first-page":"156327","DOI":"10.1016\/j.phymed.2024.156327","volume":"136","author":"VTT Nguyen","year":"2025","unstructured":"Nguyen VTT, Slotos RS, Guilherme MDS et al (2025) Ginkgo biloba extract EGb 761\u00ae ameliorates cognitive impairment and alleviates TNF\u03b1 response in 5xFAD Alzheimer\u2018s disease model mice. Phytomedicine 136:156327. https:\/\/doi.org\/10.1016\/j.phymed.2024.156327","journal-title":"Phytomedicine"},{"key":"2090_CR114","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jgr.2025.03.011","volume":"49","author":"J Hwang","year":"2025","unstructured":"Hwang J, Keum M, Choe YM et al (2025) Panax ginseng: A modulator of amyloid, tau pathology, and cognitive function in Alzheimer\u2019s disease. J Ginseng Res 49:348\u2013355. https:\/\/doi.org\/10.1016\/j.jgr.2025.03.011","journal-title":"J Ginseng Res"},{"key":"2090_CR115","doi-asserted-by":"publisher","first-page":"27045","DOI":"10.1038\/s41598-025-12937-0","volume":"15","author":"J Chen","year":"2025","unstructured":"Chen J, Wei C, Zhang Y et al (2025) Curcumin exerts neuroprotective effects on proliferation of neural stem cells in vitro and APP\/PS1 mouse model in vivo. Sci Rep 15:27045. https:\/\/doi.org\/10.1038\/s41598-025-12937-0","journal-title":"Sci Rep"},{"key":"2090_CR116","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/antiox13101164","volume":"13","author":"N Gladen-Kolarsky","year":"2024","unstructured":"Gladen-Kolarsky N, Monestime O, Bollen M et al (2024) Withania somnifera (Ashwagandha) Improves Spatial Memory, Anxiety and Depressive-like Behavior in the 5xFAD Mouse Model of Alzheimer\u2019s Disease. Antioxidants 13:1164. https:\/\/doi.org\/10.3390\/antiox13101164","journal-title":"Antioxidants"},{"key":"2090_CR117","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1080\/01480545.2020.1833907","volume":"45","author":"Z Firdaus","year":"2022","unstructured":"Firdaus Z, Singh N, Prajapati SK et al (2022) Centella asiatica prevents D-galactose-Induced cognitive deficits, oxidative stress and neurodegeneration in the adult rat brain. Drug Chem Toxicol 45:1417\u20131426. https:\/\/doi.org\/10.1080\/01480545.2020.1833907","journal-title":"Drug Chem Toxicol"},{"key":"2090_CR118","doi-asserted-by":"publisher","first-page":"101930","DOI":"10.1016\/j.bbrep.2025.101930","volume":"41","author":"FG Babaei","year":"2025","unstructured":"Babaei FG, Saburi E, Forouzanfar F et al (2025) Effect of epigallocatechin-3-gallate (EGCG) on cognitive functioning and the expression of APP and BDNF in the hippocampus of rats with streptozotocin -induced Alzheimer-like disease. Biochem Biophys Rep 41:101930. https:\/\/doi.org\/10.1016\/j.bbrep.2025.101930","journal-title":"Biochem Biophys Rep"},{"key":"2090_CR119","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12906-022-03605-1","volume":"22","author":"G Margetts","year":"2022","unstructured":"Margetts G, Kleidonas S, Zaibi NS et al (2022) Evidence for anti-inflammatory effects and modulation of neurotransmitter metabolism by Salvia officinalis L. BMC Complement Med Ther 22:131. https:\/\/doi.org\/10.1186\/s12906-022-03605-1","journal-title":"BMC Complement Med Ther"},{"key":"2090_CR120","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.2174\/0115680266357793241223100307","volume":"25","author":"M Verma","year":"2025","unstructured":"Verma M, Mohd Siddique MU, Singh NK (2025) Neuroactive Phytoconstituents of Glycyrrhiza glabra for the Treatment of Alzheimer\u2019s Disease. CTMC 25:1251\u20131265. https:\/\/doi.org\/10.2174\/0115680266357793241223100307","journal-title":"CTMC"},{"key":"2090_CR121","doi-asserted-by":"publisher","first-page":"117564","DOI":"10.1016\/j.jep.2023.117564","volume":"321","author":"Y Li","year":"2024","unstructured":"Li Y, Wu H, Liu M et al (2024) Polysaccharide from Polygala tenuifolia alleviates cognitive decline in Alzheimer\u2019s disease mice by alleviating A\u03b2 damage and targeting the ERK pathway. J Ethnopharmacol 321:117564. https:\/\/doi.org\/10.1016\/j.jep.2023.117564","journal-title":"J Ethnopharmacol"},{"key":"2090_CR122","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12906-025-04771-8","volume":"25","author":"J Zhao","year":"2025","unstructured":"Zhao J, Li Z, Zhang R et al (2025) Network pharmacology mechanism of Rosmarinus officinalis L.(Rosemary) to improve cell viability and reduces apoptosis in treating Alzheimer\u2019s disease. BMC Complement Med Ther 25:94. https:\/\/doi.org\/10.1186\/s12906-025-04771-8","journal-title":"BMC Complement Med Ther"},{"key":"2090_CR123","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/molecules28020583","volume":"28","author":"T Xia","year":"2023","unstructured":"Xia T, Zhang J, Guo Y et al (2023) Humulus lupulus L. Extract Protects against Senior Osteoporosis through Inhibiting Amyloid \u03b2 Deposition and Oxidative Stress in APP\/PS1 Mutated Transgenic Mice and Osteoblasts. Molecules 28:583. https:\/\/doi.org\/10.3390\/molecules28020583","journal-title":"Molecules"},{"key":"2090_CR124","doi-asserted-by":"publisher","first-page":"157342","DOI":"10.1016\/j.phymed.2025.157342","volume":"148","author":"V Nischang","year":"2025","unstructured":"Nischang V, Bachmann V, Perkowski BJ et al (2025) Boswellia serrata extract with low 3O-acetyl-11-keto-\u03b2-boswellic acid-content causes efficient lipid mediator class switch. Phytomedicine 148:157342. https:\/\/doi.org\/10.1016\/j.phymed.2025.157342","journal-title":"Phytomedicine"},{"key":"2090_CR125","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s12031-025-02437-1","volume":"75","author":"TA Kopi","year":"2025","unstructured":"Kopi TA, Shanehbandpour-Tabari F, Arani RM et al (2025) Piperine Prevents Scopolamine-Induced Cognitive Impairment via its Antioxidant and Anti-Inflammatory Roles; Suggesting Potential Modulation of Necroptosis-Related Genes Including MLKL and TNF-\u03b1. J Mol Neurosci 75:142. https:\/\/doi.org\/10.1007\/s12031-025-02437-1","journal-title":"J Mol Neurosci"},{"key":"2090_CR126","doi-asserted-by":"publisher","first-page":"149918","DOI":"10.1016\/j.brainres.2025.149918","volume":"1866","author":"SA \u00c7am \u00d6z\u00fcnl\u00fc","year":"2025","unstructured":"\u00c7am \u00d6z\u00fcnl\u00fc SA, Uysal F, Tatl\u0131 Do\u011fan H et al (2025) Thymoquinone ameliorates cognitive impairment and neuroinflammation in an amyloid-beta-induced rat model of Alzheimer\u2019s disease. Brain Res 1866:149918. https:\/\/doi.org\/10.1016\/j.brainres.2025.149918","journal-title":"Brain Res"},{"key":"2090_CR127","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.jpsychires.2012.03.003","volume":"46","author":"H Herrschaft","year":"2012","unstructured":"Herrschaft H, Nacu A, Likhachev S et al (2012) Ginkgo biloba extract EGb 761\u00ae in dementia with neuropsychiatric features: A randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240\u00a0mg. J Psychiatr Res 46:716\u2013723. https:\/\/doi.org\/10.1016\/j.jpsychires.2012.03.003","journal-title":"J Psychiatr Res"},{"key":"2090_CR128","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jep.2013.11.008","volume":"151","author":"C Kongkeaw","year":"2014","unstructured":"Kongkeaw C, Dilokthornsakul P, Thanarangsarit P et al (2014) Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. J Ethnopharmacol 151:528\u2013535. https:\/\/doi.org\/10.1016\/j.jep.2013.11.008","journal-title":"J Ethnopharmacol"},{"key":"2090_CR129","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/antiox11020215","volume":"11","author":"KM Wright","year":"2022","unstructured":"Wright KM, Bollen M, David J et al (2022) Pharmacokinetics and Pharmacodynamics of Key Components of a Standardized Centella asiatica Product in Cognitively Impaired Older Adults: A Phase 1, Double-Blind, Randomized Clinical Trial. Antioxidants 11:215. https:\/\/doi.org\/10.3390\/antiox11020215","journal-title":"Antioxidants"},{"key":"2090_CR130","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1177\/02698811251324377","volume":"39","author":"HP Rai","year":"2025","unstructured":"Rai HP, Mishra DN (2025) Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On\u2122) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study. J Psychopharmacol 39:350\u2013363. https:\/\/doi.org\/10.1177\/02698811251324377","journal-title":"J Psychopharmacol"},{"key":"2090_CR131","doi-asserted-by":"publisher","unstructured":"Chowdhury D, Roy AK, Reddy VR et al (2024) Multicenter, open-label, prospective study shows safety and therapeutic benefits of a defined ginkgo biloba extract for adults with Major Neurocognitive Disorder. https:\/\/doi.org\/10.1159\/000540385. Dement Geriatr Cogn Disord","DOI":"10.1159\/000540385"},{"key":"2090_CR132","doi-asserted-by":"publisher","first-page":"1222708","DOI":"10.3389\/frdem.2023.1222708","volume":"2","author":"SS Das","year":"2023","unstructured":"Das SS, Gopal PM, Thomas JV et al (2023) Influence of CurQfen\u00ae-curcumin on cognitive impairment: a randomized, double-blinded, placebo-controlled, 3-arm, 3-sequence comparative study. Front Dement 2:1222708. https:\/\/doi.org\/10.3389\/frdem.2023.1222708","journal-title":"Front Dement"},{"key":"2090_CR133","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12937-024-01039-8","volume":"23","author":"S Galluzzi","year":"2024","unstructured":"Galluzzi S, Marizzoni M, Gatti E et al (2024) Citrus supplementation in subjective cognitive decline: results of a 36-week, randomized, placebo-controlled trial. Nutr J 23:135. https:\/\/doi.org\/10.1186\/s12937-024-01039-8","journal-title":"Nutr J"},{"key":"2090_CR134","doi-asserted-by":"publisher","first-page":"100271","DOI":"10.1016\/j.tjpad.2025.100271","volume":"12","author":"L Forcano","year":"2025","unstructured":"Forcano L, Soldevila-Domenech N, Boronat A et al (2025) A multimodal lifestyle intervention complemented with epigallocatechin gallate to prevent cognitive decline in APOE- \u025b4 carriers with Subjective Cognitive Decline: a randomized, double-blinded clinical trial (PENSA study). J Prev Alzheimer\u2019s Disease 12:100271. https:\/\/doi.org\/10.1016\/j.tjpad.2025.100271","journal-title":"J Prev Alzheimer\u2019s Disease"},{"key":"2090_CR135","doi-asserted-by":"publisher","first-page":"100574","DOI":"10.1016\/j.hermed.2022.100574","volume":"34","author":"L Rasi Marzabadi","year":"2022","unstructured":"Rasi Marzabadi L, Fazljou SMB, Araj-Khodaei M et al (2022) Saffron reduces some inflammation and oxidative stress markers in donepezil-treated mild-to-moderate Alzheimer\u2019s Disease patients: A randomized double-blind placebo-control trial. J Herb Med 34:100574. https:\/\/doi.org\/10.1016\/j.hermed.2022.100574","journal-title":"J Herb Med"},{"key":"2090_CR136","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/nyas.13431","volume":"1403","author":"C Sawda","year":"2017","unstructured":"Sawda C, Moussa C, Turner RS (2017) Resveratrol for Alzheimer\u2019s disease. Ann N Y Acad Sci 1403:142\u2013149. https:\/\/doi.org\/10.1111\/nyas.13431","journal-title":"Ann N Y Acad Sci"},{"key":"2090_CR137","doi-asserted-by":"publisher","first-page":"1561702","DOI":"10.3389\/fphar.2025.1561702","volume":"16","author":"R Sneha Sri","year":"2025","unstructured":"Sneha Sri R, Pavithra T, Vinciya T et al (2025) Integrative approaches in Alzheimer\u2019s disease: evaluating the potential of traditional, complementary, and integrative medicine (TCIM). Front Pharmacol 16:1561702. https:\/\/doi.org\/10.3389\/fphar.2025.1561702","journal-title":"Front Pharmacol"},{"key":"2090_CR138","doi-asserted-by":"publisher","first-page":"126599","DOI":"10.1016\/j.ijpharm.2026.126599","volume":"691","author":"HN Shivakumar","year":"2026","unstructured":"Shivakumar HN, Shinde R, Somasekhar V et al (2026) Activation-modulated stimuli-responsive systems: an intelligent platform for site-specific gastroretentive delivery of diverse therapeutic agents. Int J Pharm 691:126599. https:\/\/doi.org\/10.1016\/j.ijpharm.2026.126599","journal-title":"Int J Pharm"},{"key":"2090_CR139","doi-asserted-by":"publisher","first-page":"126990","DOI":"10.1016\/j.ijpharm.2026.126990","volume":"699","author":"SP Sanjana","year":"2026","unstructured":"Sanjana SP, Shivakumar HN, Shinde R et al (2026) Development and in vivo evaluation of novel bioresponsive nanocubosomal in-situ gelling system for ophthalmic delivery of Amphotericin B. Int J Pharm 699:126990. https:\/\/doi.org\/10.1016\/j.ijpharm.2026.126990","journal-title":"Int J Pharm"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-026-02090-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-026-02090-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-026-02090-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:00:59Z","timestamp":1791471659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-026-02090-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":139,"alternative-id":["2090"],"URL":"https:\/\/doi.org\/10.1007\/s11418-026-02090-x","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"6 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}